CNS Co (TSE:4076) ROCE %: 16.14% (As of Nov. 2025)


TSE:4076 CNS Co Ltd TSE:4076
85 GF Score
Price 円1,741.00
GF Value 円1,971.09
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is CNS Co ROCE %?

CNS Co TSE:4076 +1.81% 85 ROCE % is 16.14% as of Nov. 2025. GuruFocus rates TSE:4076 with a GF Score™ of 85/100 and a GF Value™ of 円1,971.09 (Modestly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CNS Co's annualized ROCE % for the quarter that ended in Nov. 2025 was 16.14%.

CNS Co  (TSE:4076) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CNS Co ROCE % Related Terms

CNS Co ROCE % Historical Data

* Premium members only.

The historical data trend for CNS Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CNS Co ROCE % Chart

CNS Co Annual Data
Trend May19 May20 May21 May22 May23 May24 May25
ROCE %
Get a 7-Day Free Trial 21.68 20.51 16.42 16.22 13.72

CNS Co Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.26 12.92 20.97 16.14 18.55
TSE:4076
85GF Score
CNS Co Ltd TSE:4076
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CNS Co ROCE % Calculation

CNS Co's annualized ROCE % for the fiscal year that ended in May. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: May. 2025 )  (A: May. 2024 )(A: May. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: May. 2025 )  (A: May. 2024 )(A: May. 2025 )
=582.765/( ( (4933.509 - 834.21) + (5259.857 - 861.986) )/ 2 )
=582.765/( (4099.299+4397.871)/ 2 )
=582.765/4248.585
=13.72 %

CNS Co's ROCE % of for the quarter that ended in Nov. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Nov. 2025 )  (Q: Aug. 2025 )(Q: Nov. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Nov. 2025 )  (Q: Aug. 2025 )(Q: Nov. 2025 )
=709.964/( ( (5171.701 - 833.379) + (5830.896 - 1373.411) )/ 2 )
=709.964/( ( 4338.322 + 4457.485 )/ 2 )
=709.964/4397.9035
=16.14 %

(1) Note: The EBIT data used here is four times the quarterly (Nov. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 16.14% mean?
CNS Co (TSE:4076) has a ROCE % of 16.14% as of Nov. 2025.
Is CNS Co's ROCE % too high?
CNS Co's current ROCE % is 16.14%. The Software industry median ROCE % is 5.19. CNS Co's value of 16.14% is 211% above this industry median. Overall, CNS Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CNS Co's ROCE % compare to IBM and ACN?
CNS Co's ROCE % of 16.14% can be compared against companies in the Software industry. The industry median ROCE % is 5.19. CNS Co's value of 16.14% is 211% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Software company?
The median ROCE % among Software companies is 5.19, based on 2,709 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CNS Co's current ROCE % of 16.14% is 211% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median ROCE % is 5.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CNS Co's current ROCE % is 16.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNS Co stock overvalued right now?
Based on GuruFocus' analysis, CNS Co (TSE:4076) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,971.09, compared to a current price of 円1,741.00 — trading 11.7% below its estimated fair value. The current ROCE % is 16.14% and 211% above the Software industry median of 5.19. CNS Co's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For CNS Co (TSE:4076), the current ROCE % is 16.14% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CNS Co (TSE:4076) Overvalued in 2026?

Based on GuruFocus' analysis, CNS Co stock appears to be undervalued. The current stock price of 円1,741.00 is trading 11.7% below its estimated GF Value™ of 円1,971.09. GuruFocus considers CNS Co to be Modestly Undervalued.

Key valuation signals for TSE:4076:

  • ROCE %: 16.14%
  • GF Value™: 円1,971.09 vs. price of 円1,741.00 (11.7% below fair value)
  • GF Score™: 85/100 with 1 warning sign
  • Industry Position: 211% above the Software median

No single metric tells the full story. See the TSE:4076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CNS Co Business Description

Address 1-5-5 Ebisu Minami, 9th Floor, JR Ebisu Building, Shibuya-ku, Tokyo, JPN, 150-0022
CNS Co Ltd is an information technology solutions company engaged in providing system engineering services. The company offers various solutions to its clients such as consulting services related to digital transformation, data analysis solutions, business system integration, and the implementation, construction, and operation of optimal system infrastructure.
85GF Score

Get the complete analysis for TSE:4076

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,741.00
Price
円1,971.09
GF Value